Zydus Cadila's US Firm Gets US Food And Drug Administration Approval To Market Roflumilast Tablets

Cadlia Healthcare Ltd on Monday said group firm Zydus Pharmaceuticals (USA) Inc has received final approval from the US health regulator to market its generic version of Roflumilast tablets in the strength of 500 mcg indicated to reduce the risk of

Related Keywords

Ahmedabad ,Gujarat ,India , ,Zydus Pharmaceuticals United States Inc ,Drug Administration ,Cadila Healthcare Ltd On ,Zydus Cadila ,Approval To Market Roflumilast Tablets ,Healthcare Ltd ,Zydus Pharmaceuticals ,United States ,Roflumilast Tablets ,Cadlia Healthcare ,Zydus ,Usfda Approval ,